MedPath

Investigation the effect of imprpving on postprandial blood glucose with type 2 diabetic patients by the combination of bran ingestion and alpha glucosidase inhibitor

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000025998
Lead Sponsor
St Marianna University school of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1. Type 1 diabetic patients 2. Patients who have used alpha GI and GLP 1 analog preparations so far 3. Patients using alpha glucosidase inhibitor and GLP-1 analog preparations 4. Women who may be pregnant or may become pregnant 5. Women who are breastfeeding 6. Women in menstruation during the study period 7. Patients determined by the attending physician to be unsuitable for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1 Mean blood glucose of 24 hours 2 MAGE (average value of differences in blood glucose level when blood glucose fluctuation exceeding average + 1SD) 3 total area of blood glucose fluctuation in 24 hours 4 Percentage of time zone of hyperglycemia (> 140 mg / dL) 5 Percentage of time zone of hypoglycemia (<70 mg / dL)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath